Ligand validation:1ZM4

TAD: BETA-METHYLENE-THIAZOLE-4-CARBOXYAMIDE-ADENINE DINUCLEOTIDE

TAD is a Ligand Of Interest in 1ZM4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1ZM4_TAD_B_700	45%	23%	0.177	0.91	1.19	1.97	4	10	2	0	100%	1
1ZM4_TAD_F_702	43%	23%	0.185	0.908	1.21	1.95	4	10	3	0	100%	1
1ZM4_TAD_D_701	40%	24%	0.19	0.9	1.19	1.93	4	10	2	0	100%	1
1AER_TAD_A_700	57%	23%	0.13	0.903	1.18	1.97	3	10	0	0	100%	1
3BUZ_TAD_A_500	51%	26%	0.172	0.926	1.36	1.65	5	9	3	0	100%	1
1OG1_TAD_A_1227	20%	11%	0.192	0.795	2.33	1.89	13	8	3	0	100%	0.8

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.